Anti-cancer drugs for the treatment of leukaemias I, constituted

Details Anti-cancer drugs for the treatment of leukaemias I, constituted Anti-cancer drugs for the treatment of leukaemias I, constituted

1982-11-01

1987-02-17

Rose, Shep K.

Drug, bio-affecting and body treating compositions

Lymphokine

424 88, A61K 3900, A61K 3578

Patent

active

046438955

ABSTRACT:
The present invention relates to an anti-cancer drug, characterized in that it contains at least one product constituted by the chain A of recin conjugated by means of a disulfide bridge with at least one fraction of a monoclonal antibody of leukaemic anti-cell specificity, and to the processes for preparing the active ingredient of said drug.

REFERENCES:
Royston et al., J. of Immunology, 125 (2), 725-731 (1980).
Blythman et al., Nature, vol. 290, pp. 145-146, Mar. 12, 1981.

Affiliated with

Also associated with

Rating

Anti-cancer drugs for the treatment of leukaemias I, constituted does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-cancer drugs for the treatment of leukaemias I, constituted, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-cancer drugs for the treatment of leukaemias I, constituted will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1938246